Page last updated: 2024-08-23

substance p and Myofascial Pain Syndromes

substance p has been researched along with Myofascial Pain Syndromes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Hsieh, YL; Yang, CC; Yang, NP1
Hsieh, YL; Wu, BT; Yang, CC1
Brezinschek, HP1
Danoff, JV; Desai, MJ; Gerber, LH; Nakamura, LY; Parikh, S; Phillips, TM; Shah, JP1
Biasi, G; De Stefano, R; Franceschini, E; Frati, E; Manganelli, S; Marcolongo, R; Selvi, E; Villanova, M1
Austermann, K; Göbel, H; Heinze, A; Heinze-Kuhn, K1

Reviews

2 review(s) available for substance p and Myofascial Pain Syndromes

ArticleYear
[Mechanisms of muscle pain : significance of trigger points and tender points].
    Zeitschrift fur Rheumatologie, 2008, Volume: 67, Issue:8

    Topics: Connective Tissue; Diagnosis, Differential; Fibromyalgia; Humans; Inflammation Mediators; Muscle, Skeletal; Myofascial Pain Syndromes; Pain, Referred; Palpation; Substance P

2008
[Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Der Nervenarzt, 2001, Volume: 72, Issue:4

    Topics: Analgesics, Non-Narcotic; Botulinum Toxins, Type A; Clinical Trials as Topic; Cluster Headache; Dystonic Disorders; Facial Neuralgia; Germany; Headache Disorders; Humans; Migraine Disorders; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Neuromuscular Agents; Practice Guidelines as Topic; Substance P

2001

Other Studies

4 other study(ies) available for substance p and Myofascial Pain Syndromes

ArticleYear
Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction.
    International journal of molecular sciences, 2021, Sep-14, Volume: 22, Issue:18

    Topics: Animals; Chronic Pain; Disease Models, Animal; Electromyography; Electrophysiological Phenomena; Masticatory Muscles; Motor Endplate; Myofascial Pain Syndromes; Parabrachial Nucleus; Proto-Oncogene Proteins c-fos; Rats; Receptors, Opioid, mu; Substance P; Temporomandibular Joint Disorders; Transcutaneous Electric Nerve Stimulation

2021
Increased substance P-like immunoreactivities in parabrachial and amygdaloid nuclei in a rat model with masticatory myofascial pain.
    Experimental brain research, 2020, Volume: 238, Issue:12

    Topics: Amygdala; Animals; Chronic Pain; Myofascial Pain Syndromes; Nociception; Rats; Substance P

2020
Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points.
    Archives of physical medicine and rehabilitation, 2008, Volume: 89, Issue:1

    Topics: Analysis of Variance; Calcitonin Gene-Related Peptide; Capillary Electrochromatography; Electrophoresis; Humans; Inflammation; Inflammation Mediators; Interleukin-1beta; Microdialysis; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Pain Measurement; Serotonin; Specimen Handling; Substance P; Tumor Necrosis Factor-alpha

2008
Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome.
    The Journal of rheumatology, 2000, Volume: 27, Issue:12

    Topics: Adult; Analysis of Variance; Female; Fibromyalgia; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Middle Aged; Muscle, Skeletal; Myofascial Pain Syndromes; Neurons, Afferent; Substance P

2000